ISSN 1300-4948 | E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Effects of calcium channel blocking agents on tetracycline hepatotxicity
(Turk J Gastroenterol 1996; 7: 6-9)
The action of a calcium channel blocker (verapamil) on gallbloadder contractions
(Turk J Gastroenterol 1998; 9: 123-125)
The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice
(Turk J Gastroenterol 2009; 20: 168-191)
DOI: 10.4318/tjg.2009.0005
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Does omeprazole alter the salivary gland functions?
(Turk J Gastroenterol 2001; 12: 113-116)
Review
Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
(Turk J Gastroenterol 2017; 28: 31-32)
DOI: 10.5152/tjg.2017.09
Which drugs are risk factors for the development of gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 38-43)
DOI: 10.5152/tjg.2017.11
What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?
(Turk J Gastroenterol 2017; 28: 57-60)
DOI: 10.5152/tjg.2017.15
Gastroesophageal reflux disease and the relationship with Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 61-67)
DOI: 10.5152/tjg.2017.16
When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?
(Turk J Gastroenterol 2017; 28: 68-70)
DOI: 10.5152/tjg.2017.17
What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed?
(Turk J Gastroenterol 2017; 28: 71-72)
DOI: 10.5152/tjg.2017.18
Original Article
Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer
(Turk J Gastroenterol 2016; 27: 227-232)
DOI: 10.5152/tjg.2016.15375
Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study
(Turk J Gastroenterol 2017; 28: 104-109)
DOI: 10.5152/tjg.2016.0284
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2017 Turkish Society of Gastroenterology | Latest Update: 30.11.2017